← Leaderboards
Jose Carlos Florez
Massachusetts General Hospital
$39,251,920
Attributed
$51,272,840
Total exposure
17
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $10.9M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$63,282,534 · 19
By mechanism
R01$22,198,888 · 6
U01$19,377,462 · 2
U54$10,477,035 · 2
UM1$3,974,185 · 1
P30$3,685,479 · 3
K24$1,438,470 · 2
Top collaborators
- Monique Marie Hedderson10 shared
- Joel N Hirschhorn8 shared
- Kathleen M Giacomini6 shared
- Chirag J. Patel6 shared
- Louis H. Philipson5 shared
- Sook Wah Yee4 shared
- Anna Louise Gloyn2 shared
- Karen L Mohlke2 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Suzanne McCluskey$4,542,101
- Sanjay K Nigam$28,101,639
- Geoffrey A. Walford$338,237
- Michael W. Otto$8,919,189
- Cindy Hong Ta Pau$65,448
Others in their field
Top investigators on “Diabetes Mellitus”
- Jeffrey P Krischer · University Of South Florida$608,226,434
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$177,347,135
- John M Lachin · George Washington University$155,262,668
- David M Nathan · Massachusetts Institute Of Technology$142,806,023
- Judith S Hochman · New York University School Of Medicine$100,149,457
- Jose A Luchsinger · Columbia University Health Sciences$75,551,718
Research focus
Diabetes MellitusNon-Insulin-Dependent Diabetes MellitusResourcesGeneticGenesVariantSamplingPhenotypeGenetic VariantGenome Wide Association StudyResponseTraitGenomicsResearch PersonnelGenotypeParticipantBiologicalPathway InteractionsCollaborationsData SetCohortBaseMeta-AnalysisInternational
Grant awards (84)
A functional genomics pipeline for genetic discovery in diabetic kidney disease$622,668
R01 · FY2025 · DK
Mentoring Investigators on the Clinical Translation of Cardiometabolic Genetic Discoveries$125,295
K24 · FY2025 · HL · contact PI
Pharmacogenetic discovery in the GRADE comparative effectiveness type 2 diabetes clinical trial$622,623
R01 · FY2024 · DK · contact PI
A functional genomics pipeline for genetic discovery in diabetic kidney disease$600,931
R01 · FY2024 · DK
Admin Core$347,923
P30 · FY2024 · DK · contact PI
Mentoring Investigators on the Clinical Translation of Cardiometabolic Genetic Discoveries$125,295
K24 · FY2024 · HL · contact PI
Pharmacogenetic discovery in the GRADE comparative effectiveness type 2 diabetes clinical trial$650,707
R01 · FY2023 · DK · contact PI
A functional genomics pipeline for genetic discovery in diabetic kidney disease$631,482
R01 · FY2023 · DK
Discovery of Pharmacogenomic Biomarkers for OATP1B1 and OATP1B3$578,966
R01 · FY2023 · GM
Mentoring Investigators on the Clinical Translation of Cardiometabolic Genetic Discoveries$125,295
K24 · FY2023 · HL · contact PI
Equipment Supplement for Discovery of Pharmacogenomic Biomarkers for OATP1B1 and OATP1B3$29,371
R01 · FY2023 · GM
Center for Identification and Study of Individuals with Atypical Diabetes Mellitus$1,406,000
U54 · FY2022 · DK
A functional genomics pipeline for genetic discovery in diabetic kidney disease$718,589
R01 · FY2022 · DK · contact PI
Pharmacogenetic discovery in the GRADE comparative effectiveness type 2 diabetes clinical trial$652,262
R01 · FY2022 · DK · contact PI
Discovery of Pharmacogenomic Biomarkers for OATP1B1 and OATP1B3$585,886
R01 · FY2022 · GM
Mentoring Investigators on the Clinical Translation of Cardiometabolic Genetic Discoveries$125,295
K24 · FY2022 · HL · contact PI
Bridging the gap between type 2 diabetes GWAS and therapeutic targets$1,948,933
UM1 · FY2021 · DK
Pharmacogenetic discovery in the GRADE comparative effectiveness type 2 diabetes clinical trial$704,872
R01 · FY2021 · DK · contact PI
Discovery of Pharmacogenomic Biomarkers for OATP1B1 and OATP1B3$599,475
R01 · FY2021 · GM
Harvard Training Program in Bioinformatics Applied to Diabetes, Obesity and Metabolism.$243,768
T32 · FY2021 · DK · contact PI
Center for Identification and Study of Individuals with Atypical Diabetes Mellitus$163,898
U54 · FY2021 · DK
Mentoring Investigators on the Clinical Translation of Cardiometabolic Genetic Discoveries$125,295
K24 · FY2021 · HL · contact PI
Center for Identification and Study of Individuals with Atypical Diabetes Mellitus$2,500,000
U54 · FY2020 · DK
Bridging the gap between type 2 diabetes GWAS and therapeutic targets$2,025,252
UM1 · FY2020 · DK
Discovery of Pharmacogenomic Biomarkers for OATP1B1 and OATP1B3$624,418
R01 · FY2020 · GM
Harvard Training Program in Bioinformatics Applied to Diabetes, Obesity and Metabolism.$318,676
T32 · FY2020 · DK · contact PI
Mentoring Investigators on the Clinical Translation of Genetic Discoveries in Type 2 Diabetes$162,399
K24 · FY2020 · DK · contact PI
Proposal for the AMP T2D-GENES Data Coordination Center and Web Portal$2,678,649
U01 · FY2019 · DK · contact PI
Center for Identification and Study of Individuals with Atypical Diabetes Mellitus$2,500,000
U54 · FY2019 · DK
Boston Area Diabetes Endocrinology Research Center$1,469,898
P30 · FY2019 · DK · contact PI
Integrative genomic, epigenetic and functional studies in diabetic kidney disease$725,688
R01 · FY2019 · DK
Proposal for the AMP T2D-GENES Data Coordination Center and Web Portal$630,976
U01 · FY2019 · DK · contact PI
Proposal for the AMP T2D-GENES Data Coordination Center and Web Portal$439,923
U01 · FY2019 · DK · contact PI
Administrative Core$397,760
P30 · FY2019 · DK · contact PI
Harvard Training Program in Bioinformatics Applied to Diabetes, Obesity and Metabolism.$299,695
T32 · FY2019 · DK · contact PI
Mentoring Investigators on the Clinical Translation of Genetic Discoveries in Type 2 Diabetes$162,399
K24 · FY2019 · DK · contact PI
Harvard Training Program in Bioinformatics Applied to Diabetes, Obesity and Metabolism.$31,337
T32 · FY2019 · DK · contact PI
Proposal for the AMP T2D-GENES Data Coordination Center and Web Portal$2,679,210
U01 · FY2018 · DK · contact PI
Center for Identification and Study of Individuals with Atypical Diabetes Mellitus$2,500,000
U54 · FY2018 · DK
Boston Area Diabetes Endocrinology Research Center$1,469,898
P30 · FY2018 · DK · contact PI
Discovery and Analysis Program$1,407,137
U54 · FY2018 · DK · contact PI
Proposal for the AMP T2D-GENES Data Coordination Center and Web Portal$989,090
U01 · FY2018 · DK · contact PI
Integrative genomic, epigenetic and functional studies in diabetic kidney disease$730,384
R01 · FY2018 · DK
Discovery of Pharmacogenomic Biomarkers for Metformin Response$720,081
R01 · FY2018 · GM
Harvard Training Program in Bioinformatics Applied to Diabetes, Obesity and Metabolism.$271,143
T32 · FY2018 · DK · contact PI
Mentoring Investigators on the Clinical Translation of Genetic Discoveries in Type 2 Diabetes$162,399
K24 · FY2018 · DK · contact PI
Proposal for the AMP T2D-GENES Data Coordination Center and Web Portal$2,633,309
U01 · FY2017 · DK · contact PI
Proposal for the AMP T2D-GENES Data Coordination Center and Web Portal$1,200,001
U01 · FY2017 · DK · contact PI
Integrative genomic, epigenetic and functional studies in diabetic kidney disease$739,431
R01 · FY2017 · DK
Discovery of Pharmacogenomic Biomarkers for Metformin Response$719,085
R01 · FY2017 · GM
A Human-Centered Pharmacogenomic Screen of Metformin Action$586,765
R01 · FY2017 · DK · contact PI
Proposal for the AMP T2D-GENES Data Coordination Center and Web Portal$193,013
U01 · FY2017 · DK · contact PI
Mentoring Investigators on the Clinical Translation of Genetic Discoveries in Type 2 Diabetes$162,399
K24 · FY2017 · DK · contact PI
Harvard Training Program in Bioinformatics Applied to Diabetes, Obesity and Metabolism.$139,986
T32 · FY2017 · DK · contact PI
Proposal for the AMP T2D-GENES Data Coordination Center and Web Portal$2,633,310
U01 · FY2016 · DK · contact PI
Integrative genomic, epigenetic and functional studies in diabetic kidney disease$845,751
R01 · FY2016 · DK
Discovery of Pharmacogenomic Biomarkers for Metformin Response$803,285
R01 · FY2016 · GM
A Human-Centered Pharmacogenomic Screen of Metformin Action$609,483
R01 · FY2016 · DK · contact PI
Proposal for the AMP T2D-GENES Data Coordination Center and Web Portal$173,465
U01 · FY2016 · DK · contact PI
Mentoring Investigators on the Clinical Translation of Genetic Discoveries in Type 2 Diabetes$162,399
K24 · FY2016 · DK · contact PI
Equipment Supplement due 5/20/2016 P0516422$24,942
R01 · FY2016 · GM
Proposal for the AMP T2D-GENES Data Coordination Center and Web Portal$2,595,046
U01 · FY2015 · DK · contact PI
Discovery of Pharmacogenomic Biomarkers for Metformin Response$837,363
R01 · FY2015 · GM
Study to Understand the Genetics of the Acute Response to Metformin & Glipizide$618,797
R01 · FY2015 · DK · contact PI
A Human-Centered Pharmacogenomic Screen of Metformin Action$557,729
R01 · FY2015 · DK · contact PI
Study to Understand the Genetics of the Acute Response to Metformin & Glipizide$618,797
R01 · FY2014 · DK · contact PI
A Human-Centered Pharmacogenomic Screen of Metformin Action$616,879
R01 · FY2014 · DK · contact PI
Multiethnic Study of Type 2 Diabetes Genes$2,531,470
U01 · FY2013 · DK · contact PI
Study to Understand the Genetics of the Acute Response to Metformin & Glipizide$590,735
R01 · FY2013 · DK · contact PI
Fine-mapping and Characterization of Metabolic Loci in the DPP Outcomes Study$519,642
R01 · FY2013 · DK · contact PI
Study to Understand the Genetics of the Acute Response to Metformin & Glipizide$563,055
R01 · FY2012 · DK · contact PI
Fine-mapping and Characterization of Metabolic Loci in the DPP Outcomes Study$554,374
R01 · FY2012 · DK · contact PI
Study to Understand the Genetics of the Acute Response to Metformin & Glipizide$579,347
R01 · FY2011 · DK · contact PI
Fine-mapping and Characterization of Metabolic Loci in the DPP Outcomes Study$562,519
R01 · FY2011 · DK · contact PI
Study to Understand the Genetics of the Acute Response to Metformin & Glipizide$2,538
R01 · FY2011 · DK · contact PI
Study to Understand the Genetics of the Acute Response to Metformin & Glipizide$766,146
R01 · FY2010 · DK · contact PI
Fine-mapping and Characterization of Metabolic Loci in the DPP Outcomes Study$683,822
R01 · FY2010 · DK · contact PI
Genetic variation in drug targets for type 2 diabetes$130,680
K23 · FY2008 · DK · contact PI
Pharmacogenetics of the acute response to sulfonylurea and metformin treatment in$85,750
R03 · FY2008 · DK · contact PI
Genetic variation in drug targets for type 2 diabetes$130,680
K23 · FY2007 · DK · contact PI
Pharmacogenetics of the acute response to sulfonylurea and metformin treatment in$87,500
R03 · FY2007 · DK · contact PI
Genetic variation in drug targets for type 2 diabetes$130,680
K23 · FY2006 · DK · contact PI
Genetic variation in drug targets for type 2 diabetes$130,680
K23 · FY2005 · DK
Genetic variation in drug targets for type 2 diabetes$130,440
K23 · FY2004 · DK